2017 has seen two key advancements for diabetes patients, but affordability remains an issue.
Diabetes and high BMI were responsible for an estimated 800,000 new cases of cancer worldwide in 2012.
Glucose lowering drugs provide additional cardiovascular benefit to patients with diabetes.
Study shows that longer sleep duration was associated with reductions in several markers for type 2 diabetes.
Patients at high risk could be identified and targeted for intervention, resulting in the potential for high healthcare cost savings.
More than twice as many adults aged 45 to 65 with diabetes reported skipping doses of medication to save money, according to new data.
Women who experienced premature or early menopause were more than twice as likely to have type 2 diabetes, a new study finds.
A lack of improvement in HbA1c compared with patients who monitor glucose indicates that monitoring should not be routine, according to new research.
Good, long-term control of HbA1c may help prevent depressive symptoms in elderly with type 2 diabetes, according to a new study.
Sticking with a prevention program for one year increased the likelihood of success